U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Compound

Items: 1 to 20 of 270

1.
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study
Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, Nils Kossack, Lena M Richter, Jing Claussen, Chris Compton, Stephen G Noorduyn, Afisi S Ismaila, Gema Requena
Int J Chron Obstruct Pulmon Dis. 2024; 19: 1835–1848. Published online 2024 Aug 9. doi: 10.2147/COPD.S460903
PMCID:
PMC11321345
AbstractArticlePDF–583K
2.
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
Shigeo Muro, Tomotaka Kawayama, Hisatoshi Sugiura, Munehiro Seki, Elizabeth A. Duncan, Karin Bowen, Jonathan Marshall, Ayman Megally, Mehul Patel
Respir Res. 2024; 25: 297. Published online 2024 Aug 5. doi: 10.1186/s12931-024-02918-8
PMCID:
PMC11302094
AbstractArticlePDF–2.0M
3.
Extrafine single inhaler triple therapy effectiveness in COPD patients previously treated with multiple-inhaler triple therapy: the TRIWIN study
Paschalis Steiropoulos, Niki Georgatou, George Krommidas, Konstantinos Bartziokas, Aliki Korkontzelou, Panos Katerelos, Petros Efstathopoulos, Dimosthenis Papapetrou, Stavros Theodorakis, Konstantinos Porpodis
Ther Adv Respir Dis. 2024 Jan-Dec; 18: 17534666241263439. Published online 2024 Jul 25. doi: 10.1177/17534666241263439
PMCID:
PMC11301738
AbstractArticlePDF–883K
4.
Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success
Hana Müllerová, Jeffrey Shi Kai Chan, Heath Heatley, Victoria Carter, John Townend, Derek Skinner, Stefan Franzén, Jonathan Marshall, David Price
Int J Chron Obstruct Pulmon Dis. 2024; 19: 1153–1166. Published online 2024 May 24. doi: 10.2147/COPD.S452624
PMCID:
PMC11134059
AbstractArticlePDF–2.3M
5.
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fränce Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Int J Chron Obstruct Pulmon Dis. 2024; 19: 945–956. Published online 2024 Apr 17. doi: 10.2147/COPD.S431291
PMCID:
PMC11032663
AbstractArticlePDF–706K
6.
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023
Maria Gabriella Matera, Luigino Calzetta, Paola Rogliani, Nicola Hanania, Mario Cazzola
Lung. 2024; 202(2): 119–125. Published online 2024 Feb 6. doi: 10.1007/s00408-024-00677-3
PMCID:
PMC11009752
AbstractArticlePDF–610K
7.
The effect of glycopyrrolate vs. atropine in combination with neostigmine on cardiovascular system for reversal of residual neuromuscular blockade in the elderly: a randomized controlled trial
Yanping Wang, Liyuan Ren, Yanshuang Li, Yinhui Zhou, Jianjun Yang
BMC Anesthesiol. 2024; 24: 123. Published online 2024 Apr 1. doi: 10.1186/s12871-024-02512-x
PMCID:
PMC10983731
AbstractArticlePDF–1.2M
8.
Sugammadex and urinary retention after hysterectomy: A propensity-matched cohort study
Mariana L De Lima Laporta Miranda, Michelle A Ochs Kinney, Jamie N Bakkum-Gamez, Darrell R Schroeder, Juraj Sprung, Toby N Weingarten
Biomol Biomed. 2024 Apr 1; 24(2): 395–400. Published online 2024 Apr 1. doi: 10.17305/bb.2023.9569
PMCID:
PMC10950351
AbstractArticlePDF–3.2M
9.
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life
Luca Richeldi, Pietro Schino, Elena Bargagli, Alberto Ricci, Alberto Rocca, Francesca Marchesani, Alfio Pennisi, Gianna Camiciottoli, Maria D’Amato, Francesco Macagno, Ulrica Scaffidi Argentina, Eleonora Ingrassia, Alessio Piraino
Int J Chron Obstruct Pulmon Dis. 2024; 19: 475–487. Published online 2024 Feb 23. doi: 10.2147/COPD.S445858
PMCID:
PMC10907130
AbstractArticlePDF–3.9M
10.
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
Charlie Strange, Joseph Tkacz, Jill Schinkel, Benjamin Lewing, Barnabie Agatep, Sean Swisher, Sushma Patel, Devechio Edwards, Daniel R Touchette, Edward Portillo, Norbert Feigler, Michael Pollack
Int J Chron Obstruct Pulmon Dis. 2023; 18: 2245–2256. Published online 2023 Oct 12. doi: 10.2147/COPD.S432963
Correction in:
Int J Chron Obstruct Pulmon Dis. 2024; 19: 1799–1800.
PMCID:
PMC10577086
AbstractArticlePDF–4.3M
11.
The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN)
Gwen S. Skloot, Alessandro Guasconi, Benjamin R. Lavon, George Georges, Wilfried De Backer, Dmitry Galkin, Mauro Cortellini, Ilaria Panni, Jason H. T. Bates
Respir Res. 2023; 24: 244. Published online 2023 Oct 6. doi: 10.1186/s12931-023-02549-5
PMCID:
PMC10559640
AbstractArticlePDF–2.8M
12.
Effect of glycopyrrolate on the postoperative urine output of patients following kidney transplantation: a retrospective observational study
Bon Sung Koo, Sun Young Park, Youn Sil Jang, Young Hoon Woo, Sanghoon Song, Jae Hwa Yoo, Mun Gyu Kim, Ji Won Chung, Sang Ho Kim, Ho Bum Cho
J Int Med Res. 2023 Oct; 51(10): 03000605231202144. Prepublished online 2023. Published online 2023 Oct 5. doi: 10.1177/03000605231202144
PMCID:
PMC10557416
AbstractArticlePDF–338K
13.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer K Quint, Afisi S Ismaila
Int J Chron Obstruct Pulmon Dis. 2023; 18: 2039–2054. Published online 2023 Sep 15. doi: 10.2147/COPD.S408688
PMCID:
PMC10508247
AbstractArticlePDF–7.3M
14.
Self-determination theory interventions versus usual care in people with diabetes: a systematic review with meta-analysis and trial sequential analysis
Anne Sophie Mathiesen, Vibeke Zoffmann, Jane Lindschou, Janus Christian Jakobsen, Christian Gluud, Mette Due-Christensen, Bodil Rasmussen, Emilie Haarslev Schröder Marqvorsen, Trine Lund-Jacobsen, Tine Bruhn Skytte, Thordis Thomsen, Mette Juel Rothmann
Syst Rev. 2023; 12: 158. Published online 2023 Sep 6. doi: 10.1186/s13643-023-02308-z
PMCID:
PMC10483731
AbstractArticlePDF–2.5M
15.
Glyoxal in hyperglycaemic ischemic stroke – a cohort study
Sina Rhein, Julica Inderhees, Oliver Herrmann, Alaa Othman, Kimberly Begemann, Thomas Fleming, Peter P. Nawroth, Karel D. Klika, Rakad Isa, Inke R. König, Georg Royl, Markus Schwaninger
Cardiovasc Diabetol. 2023; 22: 173. Published online 2023 Jul 12. doi: 10.1186/s12933-023-01892-7
PMCID:
PMC10339542
AbstractArticlePDF–1.1M
16.
The Physical Compatibility of Glycopyrrolate and Rocuronium
Austen L. Weeks, John Sotos, Bryce Woolsey, William M. Johnston, Bryant W. Cornelius
Anesth Prog. 2023 Summer; 70(2): 53–57. Published online 2023 Jun 28. doi: 10.2344/anpr-69-04-02
PMCID:
PMC10328188
AbstractArticlePDF–348K
17.
Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers
William B. Feldman, Jerry Avorn, Aaron S. Kesselheim, Joshua J. Gagne
JAMA Intern Med. 2023 Jul; 183(7): 685–695. Published online 2023 May 22. doi: 10.1001/jamainternmed.2023.1245
PMCID:
PMC10203971
AbstractArticle
18.
Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Nick Probert, Frédéric Villain, Denis Pouchain, Nathalie Texier, Stéphane Auvin
BMJ Paediatr Open. 2023; 7(1): e001913. Published online 2023 May 8. doi: 10.1136/bmjpo-2023-001913
PMCID:
PMC10173983
AbstractArticlePDF–2.0M
19.
Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study
Edward C. Portillo, Michael Pollack, Inyoung Lee, Kainan Sun, Xiaohui Zhao, Lisa Kruse, Norbert Feigler, Sushma Patel, Aimee M. Near
Ther Adv Respir Dis. 2023 Jan-Dec; 17: 17534666231164534. Published online 2023 Apr 4. doi: 10.1177/17534666231164534
PMCID:
PMC10074608
AbstractArticlePDF–1014K
20.
Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease
Corrado Pelaia, Giada Procopio, Fioramante Lello Rotundo, Maria Rosaria Deodato, Anna Ferrante Bannera, Francesco Giuseppe Tropea, Anna Cancelliere, Alessandro Vatrella, Girolamo Pelaia
Ther Adv Respir Dis. 2023 Jan-Dec; 17: 17534666231155778. Published online 2023 Feb 27. doi: 10.1177/17534666231155778
PMCID:
PMC9972048
AbstractArticlePDF–951K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center